A prospective randomized controlled trial for Yan's Jiangzhi Decoction Combined with atorvastatin in the treatment of dyslipidemia complicated with carotid atherosclerosis

Shanghai Tenth People's Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. According to the diagnosis of dyslipidemia with carotid atherosclerosis and / or plaque;
•2. TCM syndrome differentiation belongs to Spleen Qi weakness, phlegm and blood stasis block;
•3. Aged 18-70 years;
•4. Although taking lipid-lowering drugs, the drug has been stopped for more than 2 weeks, and the blood lipid level still reaches the rising standard;
•5. Patients are informed and sign informed consent voluntarily.

•1. Familial hyperlipidemia;
•2. Simple decrease of HDL;
•3. Secondary hyperlipidemia caused by drugs or other diseases;
•4. Unstable angina pectoris, acute myocardial infarction, cerebrovascular accident, or PCI in recent three months;
•5. Patients with heart failure and cardiac function NYHA >= class III; complicated with severe arrhythmia (such as frequent premature ventricular contractions, ventricular tachycardia, fast atrial fibrillation, etc.);
•6. Uncontrolled grade 3 hypertension;
•7. Body mass index (BMI)> 31;
•8. Heparin, thyroxine and other drugs affecting blood lipid metabolism are being used;
•9. Serious or unstable heart, liver, kidney, endocrine, blood and other medical diseases;
•10. Mental illness or alcohol, drug dependence, cancer, diabetes;
•11. Moderate and severe liver damage, moderate and severe abnormal liver function;
•12. Allergic constitution, lactation, pregnant women, plan to get pregnant during the trial or to make their spouse pregnant;
•13. Participated in other clinical trials within 3 months.

发起方